Edition:
India

Chembio Diagnostics Inc (CEMI.OQ)

CEMI.OQ on NASDAQ Stock Exchange Capital Market

10.30USD
15 Jun 2018
Change (% chg)

$-0.10 (-0.96%)
Prev Close
$10.40
Open
$10.30
Day's High
$10.30
Day's Low
$10.25
Volume
6,332
Avg. Vol
8,166
52-wk High
$10.40
52-wk Low
$5.70

Chart for

About

Chembio Diagnostics, Inc. (Chembio), and its subsidiary, Chembio Diagnostic Systems, Inc., develop, manufacture, market and license rapid point-of-care diagnostic tests (POCTs) that detect infectious diseases. The Company's products available are rapid tests for the detection of human immunodeficiency virus (HIV) 1/2 antibodies,... (more)

Overall

Beta: 1.19
Market Cap(Mil.): $77.55
Shares Outstanding(Mil.): 12.31
Dividend: --
Yield (%): --

Financials

  CEMI.OQ Industry Sector
P/E (TTM): -- 30.95 32.75
EPS (TTM): -0.71 -- --
ROI: -68.16 14.84 14.38
ROE: -69.09 16.34 16.07

BRIEF-Chembio Diagnostics Reports Q1 Loss Per Share $0.05

* CHEMBIO DIAGNOSTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

10 May 2018

BRIEF-Chembio Diagnostics And Lumiradx Enter Collaboration To Develop New Point-Of-Care Diagnostic Tests For Infectious Diseases

* CHEMBIO DIAGNOSTICS AND LUMIRADX ENTER COLLABORATION TO DEVELOP NEW POINT-OF-CARE DIAGNOSTIC TESTS FOR INFECTIOUS DISEASES

25 Apr 2018

BRIEF-Chembio Diagnostics Q4 Loss Per Share $0.16

* CHEMBIO DIAGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

09 Mar 2018

BRIEF-Chembio Diagnostics Announces Proposed Public Offering Of Common Stock

* CHEMBIO DIAGNOSTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

09 Feb 2018

BRIEF-Chembio Diagnostics Announces Major New Tender Win And Certain Preliminary 2017 Financial Results

* CHEMBIO DIAGNOSTICS ANNOUNCES MAJOR NEW TENDER WIN AND CERTAIN PRELIMINARY 2017 FINANCIAL RESULTS

09 Feb 2018

BRIEF-Chembio Diagnostics Appoints Neil Goldman As CFO

* CHEMBIO DIAGNOSTICS ANNOUNCES APPOINTMENT OF NEIL A. GOLDMAN AS CHIEF FINANCIAL OFFICER

20 Dec 2017

BRIEF-Chembio Diagnostics And Astrazeneca Collaborates To Develop Point-Of-Care Diagnostic Test

* CHEMBIO DIAGNOSTICS AND ASTRAZENECA ENTER A COLLABORATION TO DEVELOP POINT-OF-CARE DIAGNOSTIC TEST

19 Dec 2017

Competitors

Earnings vs. Estimates